Update on InnomarPharmacy and InnomarClinic hours and availability
InnomarClinics remain open to our patients amidst coronavirus (COVID-19) concerns.
Welcome to Canada. Let us support you through your journey.
For manufacturers new to the Canadian healthcare system, understanding our diverse regulatory and reimbursement landscape can be daunting. With 10 provinces and three territories—each with its own approach to public drug coverage, review processes, timelines and priorities—you need an experienced partner with in-depth knowledge to help guide your successful commercialization strategy.
End-to-end commercialization services
The journey to bring complex, or innovative, products into the ever evolving Canadian market requires a partner who is laser-focused on the requirements for a strategic launch and operationalizing throughout the product lifecycle.
Regulatory Affairs & Submissions
The pre-development stage of commercialization can start as early as two years before you launch in Canada. Our Regulatory experts will strategically guide and support all regulatory submission application requirements.
HEOR & Market Access
The Innomar team has highly specialized HEOR and Market Access consultants who are able to walk you through assessment of the Canadian landscape, defining data, pricing and economic value, developing a strong Public and Private Payer strategy with Real World Evidence considerations, Special Access Programme (SAP) strategy through to managing your submissions.
Importation and 3PL
Our Third-Party Logistics and Distribution teams will help mitigate financial and excursion risks, act as importer, and create seamless operational integration, customized to your current and future portfolio, with an uncompromising commitment to safe storage, handling and shipment.
Drug Safety and Quality Assurance
As you scale your business in Canada, you can rely on our highly specialized resources in Quality Assurance, Pharmacovigilance and Medical Information. Our turn key services will reduce risk, improve care, and support your growth strategy in market.
Our knowledgeable Patient Support Program (PSP) team members are trained on the intricacies of the disease and deliver customized support for patients, caregivers, and various stakeholders. As such, we know that an optimal patient experience consists of both personal interactions and digital solutions to support them in their daily life.
Launch Plan Services
Our Integrated Model is set up to facilitate your product launch and ongoing market presence. From market research and advisory board insights, to SAP transfer and bridging strategy, right through to our pharmacist’s dispensing and our nurses administering your drug. As your business continues to grow and scale, we can support you across the entire lifecycle of your product in Canada.
The right partner for a manufacturer who is new to Canada, is someone who is easy to work with, understands the landscape and understands our patients and physicians. Ultimately, you want a turnkey partner who is not just a consultant, but can also do the work.
We’re here for you at every step
Innomar Strategies doesn’t just consult on how to enter the Canadian market, we help you operationalize and deliver a consistent patient experience at every touch-point. Learn more about how our integrated services optimize product performance and enhance patient care.